Ubithera Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 10 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -0.41%
(FY 2021)
- Profit -1.40%
(FY 2021)
- Ebitda 11.61%
(FY 2021)
- Net Worth 20.25%
(FY 2021)
- Total Assets -3.32%
(FY 2021)
About Ubithera Pharma
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ingani Hyacinthe, Traore Hamidou, and Mohd Ahmad serve as directors at the Company.
- CIN/LLPIN
U24100DL2015PTC275235
- Company No.
275235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ubithera Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Ahmad  | Director | 13-Feb-2015 | Current |
Ingani Hyacinthe  | Director | 12-Jan-2015 | Current |
Traore Hamidou  | Director | 12-Jan-2015 | Current |
Financial Performance of Ubithera Pharma.
Ubithera Pharma Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.41% decrease. The company also saw a slight decrease in profitability, with a 1.4% decrease in profit. The company's net worth Soared by an impressive increase of 20.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ubithera Pharma?
In 2020, Ubithera Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ubithera Pharma?
Unlock and access historical data on people associated with Ubithera Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ubithera Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ubithera Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
